Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology aims to describe links between cancer, precision oncology, and liquid biopsy, focusing on their participation to immunotherapy management. The book provides updated information on the main applications of liquid biopsy and immunotherapy as well as interesting aspects useful for planning basic and translational research activities. It helps readers understand the central aspects of precision medicine in oncology, including the use of new generation technologies for translational and diagnostic settings and the main clinical trials in this area that may be useful during their research.
The book is a valuable source for cancer researchers, oncologists and other members of the medical and biomedical field who are interested in learning more about recent developments in liquid biopsy and its relationship with precision medicine and immunotherapy.
- Presents a “highlights section” in every chapter to help readers summarize the main aspects discussed
- Encompasses case reports to guide the reader on applying what they read in their clinical practice
- Includes several tables and figures specially created for the book to illustrate the meaning of what is expressed in the text
Cancer researchers, medical scientists, clinicians, graduate students
2. What is precision medicine in oncology?
3. Immunology and cancer
4. Liquid biopsy: a right tool in a right context?
5. How does immunotherapy raise the bar in oncology?
6. Liquid biopsy and immunotherapy: Is all that glitters gold?
7. Future perspectives
- No. of pages:
- © Academic Press 2022
- 15th January 2022
- Academic Press
- Paperback ISBN:
Antonio Russo, MD: the central theme of Dr. Russo’s studies is translational research, meaning the application of molecular genetics in cancer management. He is Principal Investigator in several national and international clinical trials and author of more than 300 peer-reviewed publications listed on Medline-PubMed. Dr. Russo focused his studies on liquid biopsy and its application into the oncology field since 2003. In the following years, he carried out numerous projects and made several collaborations with authoritative colleagues specialized in this field which end in the publication of the first text entirely dedicated to the use of liquid biopsy in the oncology field entitled: Liquid Biopsy in Cancer Patients.
Medical Oncology Director, Department of Oncology - A.O.U.P. "P. Giaccone" University Hospital, Italy
Ettore Capoluongo, PhD, is molecular geneticist whose job interests are mainly focused on cancer diagnostics and biomarkers identification. He is the Coordinator of two groups of the Italian Society of Clinical Biochemistry and Molecular Biology (SiBioC) and he has been appointed as Member of the Committee on Clinical Molecular Biology Curriculum (C-CMBC) of the IFCC. He has published over 215 publications in peer-reviewed journals.
Department of Molecular Medicine and Medical Biotechnologies, Universita Federico II - CEINGE, Biotecnologie Avanzate, Italy
Antonio Galvano, PhD, is Professor of Surgery, Oncology and Stomatology at Università degli Studi di Palermo | UNIPA. He has focused his research efforts on liquid biopsies for cancer diagnosis.
Universita degli Studi di Palermo | UNIPA · Department of Surgery, Oncology and StomaLiquid Biopsy: tology, Italy
Antonio Giordano, MD, PhD, is an Italian-American pathologist and geneticist, best known for his discovery of Rb2/p130, a tumor suppressor gene. Dr. Giordano is the president, founder and chairman of the board of the Sbarro Health Research Organization (SHRO), a nonprofit organization committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses, and to foster the training of young doctors in a spirit of professionalism and humanism.
Director of Sbarro Institute for Cancer Research and Molecular Medicine, and Center of Biotechnology College of Science and Technology, Temple University, USA
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.